Alta Wealth Advisors LLC Dexcom Inc Transaction History

Alta Wealth Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$84.98 - $122.67 $11,217 - $16,192	-132 Reduced 4.93%	2,546 $0
Q3 2022 Oct 17, 2022	SELL	$76.35 - $94.18 $122,007 - $150,499	-1,598 Reduced 37.37%	2,678 $216,000
Q2 2022 Jul 28, 2022	BUY	$67.99 - $132.89 $210,633 - $411,693	3,098 Added 262.99%	4,276 $318,000
Q1 2022 Apr 27, 2022	SELL	$94.08 - $130.2 $1,411 - $1,952	-15 Reduced 1.26%	1,178 $603,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $11,298 - $14,165	-87 Reduced 6.8%	1,193 $641,000
Q3 2021 Oct 13, 2021	SELL	$106.71 - $143.18 $1,387 - $1,861	-13 Reduced 1.01%	1,280 $700,000
Q2 2021 Aug 02, 2021	BUY	$80.99 - $107.93 $1,214 - $1,618	15 Added 1.17%	1,293 $552,000
Q1 2021 Apr 20, 2021	SELL	$84.79 - $104.74 $5,002 - $6,179	-59 Reduced 4.41%	1,278 $459,000
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $104,286 - $139,716	1,337 New	1,337 $494,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Alta Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alta Wealth Advisors LLC with notifications on news.